Human safety, tolerability, and pharmacokinetics of a novel broad-spectrum oral antiviral compound, molnupiravir, with activity against SARS-CoV-2

WP Painter, W Holman, JA Bush, F Almazedi, H Malik… - medrxiv, 2020 - medrxiv.org
Abstract Molnupiravir, EIDD-2801/MK-4482, the prodrug of the ribonucleoside analog ß-d-
N4-hydroxycytidine (NHC), has activity against a number of RNA viruses including severe …
被引用次数：20 相关文章
[PDF] archive.org

[PDF][PDF] Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral 1 Antiviral Compound, Molnupiravir, with Activity Against SARS-CoV-2 2

JE Eraut, MJ Morin, LJ Szewczyk, GR Painter - scholar.archive.org
Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral
Compound, Molnupiravir, with Activity Page 1 1 Human Safety, Tolerability, and Pharmacokinetics …

Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral Compound, Molnupiravir, with Activity Against SARS-CoV-2

WP Painter, W Holman, JA Bush, F Almazedi, H Malik… - 2020 - pesquisa.bvsalud.org
ABSTRACT Molnupiravir, EIDD-2801/MK-4482, the prodrug of the ribonucleoside analog
{beta}-d-N4-hydroxycytidine (NHC), has activity against a number of RNA viruses including …
[HTML] europepmc.org

[HTML][HTML] Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral Compound, Molnupiravir, with Activity Against SARS-CoV-2

WP Painter, W Holman, JA Bush, F Almazedi, H Malik… - 2020 - europepmc.org
Abstract Molnupiravir, EIDD-2801/MK-4482, the prodrug of the ribonucleoside analog ß-d-
N4-hydroxycytidine (NHC), has activity against a number of RNA viruses including severe …

Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral Compound, Molnupiravir, with Activity Against SARS-CoV-2

WP Painter, W Holman, JA Bush, F Almazedi, H Malik… - 2020 - pesquisa.bvsalud.org
Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral
Compound, Molnupiravir, with Activity Against SARS-CoV-2 | PREPRINT-MEDRXIV loading 1 2 …